Association of Vascular Risk With Severe vs Non-Severe Stroke An Analysis of the INTERSTROKE Study
| dc.authorid | 0000-0002-6396-5913 | |
| dc.authorid | 0000-0002-6044-7328 | |
| dc.authorid | 0000-0001-6841-4830 | |
| dc.contributor.author | Reddin, Catriona | |
| dc.contributor.author | Canavan, Michelle | |
| dc.contributor.author | Hankey, Graeme J. | |
| dc.contributor.author | Oveisgharan, Shahram | |
| dc.contributor.author | Langhorne, Peter | |
| dc.contributor.author | Wang, Xingyu | |
| dc.contributor.author | Iversen, Helle Klingenberg | |
| dc.date.accessioned | 2025-05-10T19:34:32Z | |
| dc.date.issued | 2024 | |
| dc.department | İstanbul Medeniyet Üniversitesi | |
| dc.description.abstract | Background and objectives Acute stroke is associated with a spectrum of functional deficits. The objective of this analysis was to explore whether the importance of individual risk factors differ by stroke severity, which may be of relevance to public health strategies to reduce disability. Methods INTERSTROKE is an international case-control study of risk factors of first acute stroke (recruitment 2007-August 2015) in 32 countries. Stroke severity was measured using the modified Rankin Scale (mRS) score within 72 hours of admission to hospital. Severe stroke is defined as mRS scores of 4-6 (and non-severe stroke, score of 0-3). We used multinomial logistic regression to estimate comparative odds ratios (ORs; 95% CIs) for severe and non-severe stroke and tested for heterogeneity (p(heterogeneity)). We also conducted a matched case-case analysis (matched for age, sex, country, and primary stroke subtype) to determine whether the prevalence of risk factors differed significantly between severe and non-severe stroke. A significant difference in the association of a risk factor of severe stroke compared with non-severe stroke was defined as p < 0.05 for both p(heterogeneity) and p(case-case). Results Of patients with acute stroke (n = 13,460), 64.0% (n = 8,612) were reported to have mRS scores of 0-3 and 36.0% (n = 4,848) scores of 4-6. The mean age was 61.7 years for patients with non-severe stroke and 62.9 years for patients with severe stroke (p = 0.72). 38.1% (n = 3,278) of patients with non-severe stroke and 44.6% (n = 2,162) of patients with severe stroke were female. Hypertension (OR 3.21; 95% CI 2.97-3.47 for severe stroke, OR 2.87; 95% CI 2.69-3.05 for non-severe stroke; p(heterogeneity) = 0.03; p(case-case) < 0.001), atrial fibrillation (OR 4.70; 95% CI 4.05-5.45 for severe stroke, OR 3.61; 95% CI 3.16-4.13 for non-severe stroke; p(heterogeneity) = 0.009; p(case-case) < 0.001), and smoking (OR 1.87; 95% CI 1.72-2.03 for severe stroke, OR 1.65; 95% CI 1.54-1.77 for non-severe stroke; p(heterogeneity) = 0.02; p(case-case) < 0.001) had a stronger association with severe stroke, compared with non-severe stroke. The waist-to-hip ratio had a stronger association with non-severe stroke compared with severe stroke (p(heterogeneity) < 0.001; p(case-case) < 0.001). Discussion Hypertension, atrial fibrillation, and smoking had a stronger magnitude of association with severe stroke (compared with non-severe stroke) while the increased waist-to-hip ratio had a stronger magnitude of association with non-severe stroke. | |
| dc.description.sponsorship | Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Canadian Stroke Network; Swedish Research Council; Swedish Heart and Lung Foundation; Health & Medical Care Committee of the Regional Executive Board, Regiona Vastra Gotaland (Sweden); AstraZeneca; Boehringer Ingelheim (Canada); Pfizer (Canada); MSD; Chest, Heart and Stroke Scotland; Stroke Association; UK Stroke Research Network; German Research Council (DFG); German Ministry of Education and Research (BMBF); European Union; NIH; Bertelsmann Foundation; Heinz-Nixdorf Foundation; Irish Clinical Academic Training (ICAT) Programme; Wellcome Trust; Health Research Board [203930/B/16/Z]; Health Service Executive, National Doctors Training and Planning; Health and Social Care, Research and Development Division, Northern Ireland | |
| dc.description.sponsorship | The INTERSTROKE study was funded by the Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, Canadian Stroke Network, Swedish Research Council, Swedish Heart and Lung Foundation, The Health & Medical Care Committee of the Regional Executive Board, Regiona Vastra Gotaland (Sweden), and through unrestricted grants from several pharmaceutical companies with major contributions from AstraZeneca, Boehringer Ingelheim (Canada), Pfizer (Canada), MSD, Chest, Heart and Stroke Scotland, and the Stroke Association, with support from The UK Stroke Research Network. The Department of Neurology at the University Duisburg-Essen received research grants from the German Research Council (DFG), German Ministry of Education and Research (BMBF), European Union, NIH, Bertelsmann Foundation, and Heinz-Nixdorf Foundation.CR was supported by the Irish Clinical Academic Training (ICAT) Programme, the Wellcome Trust and the Health Research Board (grant number 203930/B/16/Z), the Health Service Executive, National Doctors Training and Planning, and the Health and Social Care, Research and Development Division, Northern Ireland. | |
| dc.identifier.doi | 10.1212/WNL.0000000000210087 | |
| dc.identifier.issn | 0028-3878 | |
| dc.identifier.issn | 1526-632X | |
| dc.identifier.issue | 11 | |
| dc.identifier.pmid | 39536279 | |
| dc.identifier.scopus | 2-s2.0-85209393401 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.uri | https://doi.org/10.1212/WNL.0000000000210087 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14730/8557 | |
| dc.identifier.volume | 103 | |
| dc.identifier.wos | WOS:001397596800001 | |
| dc.identifier.wosquality | Q1 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Lippincott Williams & Wilkins | |
| dc.relation.ispartof | Neurology | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_WOS_20250302 | |
| dc.subject | Atrial-Fibrillation | |
| dc.subject | Countries | |
| dc.subject | Mortality | |
| dc.title | Association of Vascular Risk With Severe vs Non-Severe Stroke An Analysis of the INTERSTROKE Study | |
| dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1










